000 | 01116 a2200325 4500 | ||
---|---|---|---|
005 | 20250511185404.0 | ||
264 | 0 | _c19930204 | |
008 | 199302s 0 0 eng d | ||
022 | _a0271-0749 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, D W | |
245 | 0 | 0 |
_aCarbamazepine-induced increases in total serum cholesterol: clinical and theoretical implications. _h[electronic resource] |
260 |
_bJournal of clinical psychopharmacology _cDec 1992 |
||
300 |
_a431-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAffective Disorders, Psychotic _xdrug therapy |
650 | 0 | 4 |
_aCarbamazepine _xadverse effects |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aDissociative Identity Disorder _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aKetter, T A | |
700 | 1 | _aCrumlish, J | |
700 | 1 | _aPost, R M | |
773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 12 _gno. 6 _gp. 431-7 |
|
999 |
_c1480669 _d1480669 |